1.     Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–130. 
2.     Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, et al. Artesunate activates mitochondrial apoptosis in breast cancer cells via  iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem. 2011;286(8):6587–6601. 
3.     Michaelis M, Kleinschmidt MC, Barth S, Rothweiler F, Geiler J, Breitling R, et al. Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell  lines. Biochem Pharmacol. 2010;79(2):130–136. 
4.     Singh N, B V. Case report of a laryngeal squamous cell carcinoma treated with artesunate. Arch Oncol. 2002;10. 
5.     Tran TH, Nguyen TD, Poudel BK, Nguyen HT, Kim JO, Yong CS, et al. Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule  as a Potential Drug Delivery System Against Breast Cancer. AAPS PharmSciTech. 2015;16(6):1307–1316. 
6.     Wang Y, Han Y, Yang Y, Yang J, Guo X, Zhang J, et al. Effect of interaction of magnetic nanoparticles of Fe₃O₄ and artesunate on  apoptosis of K562 cells. Int J Nanomedicine. 2011;6:1185–1192. 
7.     Stella B, Arpicco S, Peracchia MT, Desmaële D, Hoebeke J, Renoir M, et al. Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci. 2000;89(11):1452–1464. 
8.     Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: Pros and cons as well as potential  alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288–6308. 
9.     Berger J, Reist M, Mayer JM, Felt O, Gurny R. Structure and interactions in chitosan hydrogels formed by complexation or  aggregation for biomedical applications. Eur J Pharm Biopharm  Off J  Arbeitsgemeinschaft fur Pharm Verfahrenstechnik eV. 2004;57(1):35–52. 
10.     Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer  therapy. Biomaterials. 2011;32(7):1890–1905. 
11.     Wang J, Chen B, Chen J, Cai X, Xia G, Liu R, et al. Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles. Int J Nanomedicine. 2011;6:203–211. 
12.     Chen B, Lai B, Cheng J, Xia G, Gao F, Xu W, et al. Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance  and induce apoptosis of K562-n/VCR cells in vivo. Int J Nanomedicine. 2009;4:201–208. 
13.     Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic  targeting of brain tumors. Biomaterials. 2008 Feb;29(4):487–496. 
14.     Chen D, Tang Q, Li X, Zhou X, Zang J, Xue W, et al. Biocompatibility of magnetic Fe₃O₄ nanoparticles and their cytotoxic effect on  MCF-7 cells. Int J Nanomedicine. 2012;7:4973–4982. 
15.     Dias AMM, Courteau A, Bellaye P-S, Kohli E, Oudot A, Doulain P-E, et al. Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through  Macrophages and Magnetic Hyperthermia. Pharmaceutics. 2022;14(11):2388. 
16.     Jain KK. Role of nanobiotechnology in developing personalized medicine for cancer. Technol Cancer Res Treat. 200;4(6):645–650. 
17.     Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical  applications. Biomaterials. 2005;26(18):3995–4021.